Average Co-Inventor Count = 5.82
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Sciences Ireland Uc (6 from 111 patents)
2. Janssen Sciences Ireland Unlimited Company (5 from 60 patents)
3. Janssen Pharmaceutica Nv (1 from 2,078 patents)
4. Janssen R&d Ireland (1 from 45 patents)
5. Tibotec Pharmaceuticals Ltd. (66 patents)
13 patents:
1. 11702426 - Macrocyclic deaza-purinones for the treatment of viral infections
2. 10829494 - Macrocyclic deaza-purinones for the treatment of viral infections
3. 10822349 - Macrocyclic purines for the treatment of viral infections
4. 10526331 - Antibacterial cyclopenta[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones
5. 10501463 - Antibacterial cyclopenta[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones
6. 10280180 - Macrocyclic purines for the treatment of viral infections
7. 10266543 - Macrocyclic deaza-purinones for the treatment of viral infections
8. 10155759 - Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones
9. 9884864 - Antibacterial cyclopenta[C]pyrrole substituted 3,4-Dihydro-1H-[1,8]naphthyridinones
10. 9617262 - Antibacterial cyclopental[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones
11. 9290493 - Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones
12. 8906923 - Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones
13. 8898047 - Methods for identifying inhibitors against viruses that use a class I fusion protein